These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 5298493

  • 1. Pipobroman (Vercyte) - a new antineoplastic drug.
    Med Lett Drugs Ther; 1967 Apr 07; 9(7):27. PubMed ID: 5298493
    [No Abstract] [Full Text] [Related]

  • 2. Chemotherapy in polycythemia vera.
    Stecher G, Reinhardt G.
    Acta Genet Med Gemellol (Roma); 1968 Jan 07; 17(1):292-302. PubMed ID: 5241850
    [No Abstract] [Full Text] [Related]

  • 3. [Therapy of polycythemia vera].
    Stecher G, Hennemann HH.
    Minerva Med; 1969 Oct 31; 60(87):4351-3. PubMed ID: 5354514
    [No Abstract] [Full Text] [Related]

  • 4. [Present treatment of the Vaquez's disease].
    Vallée G, Boivin P, Dormont J, Soulier JP.
    Presse Med (1893); 1969 Mar 22; 77(14):517-9. PubMed ID: 5783371
    [No Abstract] [Full Text] [Related]

  • 5. Primary polycythaemia. 3. Studies on the significance of the history of the disease and of the treatment for the development of clones in bone marrow cells.
    Visfeldt J, Franzén S, Nielsen A, Tribukait B.
    Acta Pathol Microbiol Scand A; 1973 Mar 22; 81(2):195-203. PubMed ID: 4734062
    [No Abstract] [Full Text] [Related]

  • 6. [The therapy of polycythemia vera].
    Hennemann HH, Stecher G.
    Dtsch Med Wochenschr; 1967 Oct 13; 92(41):1874-6. PubMed ID: 4383363
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical course and transformation of polycythemia vera and its relation to applied therapy].
    Burger T, Schmelczer M, Molnár L, Pajor L, Koszorús S.
    Orv Hetil; 1987 Dec 27; 128(52):2723-30. PubMed ID: 3431872
    [No Abstract] [Full Text] [Related]

  • 8. [Desired and undesirable effects of cytostatic therapy].
    Bartelheimer H, Frenzel H.
    Med Klin; 1967 Oct 27; 62(43):1653-9. PubMed ID: 5594047
    [No Abstract] [Full Text] [Related]

  • 9. [Efficacious treatment of a fatal blood disease: polycythemia vera].
    Sánchez Fayos J, Román Barbero A, Nevado Reviriego I.
    Sangre (Barc); 1997 Jun 27; 42(3):215-8. PubMed ID: 9381264
    [No Abstract] [Full Text] [Related]

  • 10. [Combined chemo-radionuclide therapy of cancer (complexotherapy)].
    Czerniak P, Zari A.
    Harefuah; 1971 Feb 01; 80(3):119-22. PubMed ID: 5099250
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of two antineoplastic agents, PIPOBROMAN (vercyte) and thioguanine.
    JAMA; 1967 May 15; 200(7):619-20. PubMed ID: 5228673
    [No Abstract] [Full Text] [Related]

  • 12. Management and therapy of polycythaemia vera.
    Israëls MC.
    Br J Haematol; 1969 Sep 15; 17(3):305. PubMed ID: 5257763
    [No Abstract] [Full Text] [Related]

  • 13. The treatment of Polycythemia vera and thrombocythemia with myleran (busulphan).
    Epstein IS.
    Isr J Med Sci; 1965 Jul 15; 1(4):797-9. PubMed ID: 5892718
    [No Abstract] [Full Text] [Related]

  • 14. [Polycythemia vera: therapeutic use of busulfan. Comparison with radioactive phosphorous].
    Jamra M, Verrastro T.
    Rev Hosp Clin Fac Med Sao Paulo; 1967 Jul 15; 22():Suppl:241-66. PubMed ID: 5629089
    [No Abstract] [Full Text] [Related]

  • 15. Electrophoretic patterns of human leukocyte alkaline phosphatase in polycythemia vera.
    Baxter MF, Reinfrank RF.
    Blood; 1971 May 15; 37(5):512-8. PubMed ID: 5554210
    [No Abstract] [Full Text] [Related]

  • 16. Muramidase in polycythemia vera.
    Binder RA, Gilbert HS.
    Blood; 1970 Aug 15; 36(2):228-32. PubMed ID: 5427457
    [No Abstract] [Full Text] [Related]

  • 17. Procarbazine (Natulan) and busulfan in the treatment of polycythemia vera.
    Penttilä O, Ikkala E.
    Ann Med Intern Fenn; 1968 Aug 15; 57(2):99-101. PubMed ID: 5706392
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Histologic bone marrow findings in polycythemia vera before and after P32 therapy. (At the same time a contribution to the differential diagnosis of the clinical feature "polycythemia")].
    Hauswaldt C, Hunstein W, Uhl N, Doering P.
    Arch Klin Med; 1967 Aug 15; 213(3):219-36. PubMed ID: 5594424
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.